FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pascale Coric

Research Profile

Chemicals & Drugs

Concepts & Ideas

Living Beings

Co-author Network

Publications

TOP 3
Pascale Coric; Bernard Gay; Jacques Royer; Florence Souquet; Serge Turcaud; Laurence Briant; Nathalie CHAZAL; Serge Bouaziz
Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site.
Gaëlle Gonzalez; Florence Souquet; Serge Turcaud; Serge Bouaziz; Pierre Boulanger; Pascale Coric; Sandrina DaFonseca; Elisabeth Errazuriz; Saw See Hong
Characterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assay.
Sandrina Dafonseca; Pascale Coric; Bernard Gay; Saw See Hong; Serge Bouaziz; Pierre Boulanger
The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pascale Coric (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pascale Coric; Bernard Gay; Jacques Royer; Florence Souquet; Serge Turcaud; Laurence Briant; Nathalie CHAZAL; Serge Bouaziz
Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site.
European journal of medicinal chemistry 2013;62():453-65.
2011: Gaëlle Gonzalez; Florence Souquet; Serge Turcaud; Serge Bouaziz; Pierre Boulanger; Pascale Coric; Sandrina DaFonseca; Elisabeth Errazuriz; Saw See Hong
Characterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assay.
PloS one 2011;6(11):e27234.
2008: Sandrina Dafonseca; Pascale Coric; Bernard Gay; Saw See Hong; Serge Bouaziz; Pierre Boulanger
The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.
Virology journal 2008;5():162.
2007: Victor Goncalves; Benoit Gautier; Pascale Coric; Serge Bouaziz; Christine Lenoir; Christiane Garbay; Michel Vidal; Nicolas Inguimbert
Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor.
Journal of medicinal chemistry 2007;50(21):5135-46.
2007: Victor Goncalves; Benoit Gautier; Anne Regazzetti; Pascale Coric; Serge Bouaziz; Christiane Garbay; Michel Vidal; Nicolas Inguimbert
On-resin cyclization of peptide ligands of the Vascular Endothelial Growth Factor Receptor 1 by copper(I)-catalyzed 1,3-dipolar azide-alkyne cycloaddition.
Bioorganic & medicinal chemistry letters 2007;17(20):5590-4.
2007: Sandrina DaFonseca; Armand Blommaert; Pascale Coric; Saw See Hong; Serge Bouaziz; Pierre Boulanger
The 3-O-(3',3'-dimethylsuccinyl) derivative of betulinic acid (DSB) inhibits the assembly of virus-like particles in HIV-1 Gag precursor-expressing cells.
Antiviral therapy 2007;12(8):1185-203.
2005: Nicolas Inguimbert; Pascale Coric; H Dhotel; E Bonnard; Catherine Llorens-Cortes; N Mota; Marie-Claude Fournié-Zaluski; Bernard P Roques
Synthesis and in vitro activities of new non-peptidic APA inhibitors.
The journal of peptide research : official journal of the American Peptide Society 2005;65(2):175-88.
2002: Nicolas Inguimbert; Pascale Coric; Hervé PORAS; Hervé MEUDAL; Franck Teffot; Marie-Claude Fournié-Zaluski; Bernard P Roques
Toward an optimal joint recognition of the S1' subsites of endothelin converting enzyme-1 (ECE-1), angiotensin converting enzyme (ACE), and neutral endopeptidase (NEP).
Journal of medicinal chemistry 2002;45(7):1477-86.
2000: Huixiong Chen; Florence Noble; A Mothé; Hervé MEUDAL; Pascale Coric; S Danascimento; Bernard P Roques; Pascal Guy GEORGE; Marie-Claude Fournié-Zaluski
Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: synthesis, biological properties, and antinociceptive activities.
Journal of medicinal chemistry 2000;43(7):1398-408.
1998: Huixiong Chen; Florence Noble; Pascale Coric; MC Fournie-Zaluski; Bernard P Roques
Aminophosphinic inhibitors as transition state analogues of enkephalin-degrading enzymes: a class of central analgesics.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(20):12028-33.
1998: Loic MARTIN; F Cornille; Pascale Coric; Bernard P Roques; Marie-Claude Fournié-Zaluski
Beta-amino-thiols inhibit the zinc metallopeptidase activity of tetanus toxin light chain.
Journal of medicinal chemistry 1998;41(18):3450-60.
1997: Florence Noble; C Smadja; O Valverde; Rafael Maldonado; Pascale Coric; Serge Turcaud; Marie-Claude Fournié-Zaluski; Bernard P Roques
Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical and inflammatory) of the first orally active enkephalin-metabolizing enzyme inhibitor RB 120.
Pain 1997;73(3):383-91.
1997: C Smadja; F Ruiz; Pascale Coric; Marie-Claude Fournié-Zaluski; Bernard P Roques; Rafael Maldonado
CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins.
Psychopharmacology 1997;132(3):227-36.
1996: MC Fournie-Zaluski; Pascale Coric; V Thery; W Gonzalez; Hervé MEUDAL; Serge Turcaud; Jean-Baptiste Michel; Bernard P Roques
Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.
Journal of medicinal chemistry 1996;39(13):2594-608.
1996: Pascale Coric; Serge Turcaud; Hervé MEUDAL; Bernard P Roques; MC Fournie-Zaluski
Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
Journal of medicinal chemistry 1996;39(6):1210-9.
1994: E N Chauvel; Catherine Llorens-Cortès; Pascale Coric; Sherwin Wilk; Bernard P Roques; Marie-Claude Fournié-Zaluski
Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols.
Journal of medicinal chemistry 1994;37(18):2950-7.
1994: E N Chauvel; Pascale Coric; Catherine Llorens-Cortès; Sherwin Wilk; Bernard P Roques; Marie-Claude Fournié-Zaluski
Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors.
Journal of medicinal chemistry 1994;37(9):1339-46.
1994: Marie-Claude Fournié-Zaluski; Pascale Coric; Serge Turcaud; N Rousselet; W Gonzalez; B Barbe; I Pham; N Jullian; Jean-Baptiste Michel; Bernard P Roques
New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension.
Journal of medicinal chemistry 1994;37(8):1070-83.
1994: Florence Noble; Pascale Coric; Serge Turcaud; Marie-Claude Fournié-Zaluski; Bernard P Roques
Assessment of physical dependence after continuous perfusion into the rat jugular vein of the mixed inhibitor of enkephalin-degrading enzymes, RB 101.
European journal of pharmacology 1994;253(3):283-7.
1992: Florence Noble; Pascale Coric; Marie-Claude Fournié-Zaluski; Bernard P Roques
Lack of physical dependence in mice after repeated systemic administration of the mixed inhibitor prodrug of enkephalin-degrading enzymes, RB101.
European journal of pharmacology 1992;223(1):91-6.
1992: Marie-Claude Fournié-Zaluski; Pascale Coric; Serge Turcaud; E Lucas; Florence Noble; Rafael Maldonado; Bernard P Roques
"Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes.
Journal of medicinal chemistry 1992;35(13):2473-81.
1992: Marie-Claude Fournié-Zaluski; Pascale Coric; Serge Turcaud; L Bruetschy; E Lucas; Florence Noble; Bernard P Roques
Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation.
Journal of medicinal chemistry 1992;35(7):1259-66.
1990: Bernard P Roques; G Gacel; Valérie Daugé; Ana Baamonde; G Calenco; Serge Turcaud; Pascale Coric; Marie-Claude Fournié-Zaluski
Novel approaches in the development of new analgesics.
Neurophysiologie clinique = Clinical neurophysiology 1990;20(5):369-87.